QSC unveiled a new major update for its SysNav (System Navigator) software v2.1. The QSC SysNav is an iPadOS and Windows application intended to be used with QSC’s L Class loudspeaker systems. The ...
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) and Sysnav Healthcare are collaborating to develop industry standard outcome measurements in diseases linked with movement impairments and also design the next ...
QSC is pleased to introduce a major update v2.1 for its SysNav (System Navigator) software. QSC SysNav is an iPadOS(R) and Windows(R) application intended to be used with QSC next-generation, ...
Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next ...
VERNON, France, Jan. 25, 2023 /PRNewswire/ -- Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement ...
EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials SV95C is an objective, real-world digital ambulation measure of top ...
Sysnav Healthcare SA and Roche Holding AG entered a new collaboration to develop digital endpoints for use in clinical trials of therapies for a range of neuromuscular disorders. The alliance combines ...
VERNON, France, Aug. 8, 2023 /PRNewswire/ -- SYSNAV Healthcare announces that the European Medicines Agency (EMA) considers that for ambulant Duchenne Muscular Dystrophy (DMD) patients four years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results